U.S. Personal Products Stock News

If you are trying to figure out whether 10x Genomics stock is reasonably priced or stretched, the recent share moves and current valuation score give you some useful clues to start with. The stock last closed at US$23.98, with returns of 13.8% over the past week, a decline of 2.5% over the past month, a 44.3% gain year to date, and a 188.2% gain over the past year. Over longer periods, the stock shows declines of 54.5% over three years and 85.8% over five years. Recent news coverage has...

Wondering whether Euronet Worldwide at US$67.78 is a potential bargain or a value trap? This article walks through the key signals you need to weigh before deciding how it fits in your portfolio. The stock has had a tough run, with the share price down 3.0% over the past week, 9.9% over the last month, 8.5% year to date, and 36.3% over the past year. This adds to a 39.8% decline over three years and 54.0% over five years. Recent headlines around Euronet Worldwide have focused on its position...

Provident Financial Services (NYSE:PFS) reported strong Q1 earnings with record fee income. The company highlighted robust commercial loan expansion alongside an uptick in nonperforming loans. Management also pointed to higher technology related expenses as a near term pressure point. For investors tracking NYSE:PFS, the fresh Q1 update adds additional detail beyond the share price alone. The stock most recently closed at $22.15, is up 12.2% year to date and 38.3% over the past year, and...

Investors may be wondering whether MongoDB at around US$329 per share is still a sensible entry or hold after a strong run, or whether expectations have run too far ahead of reality. Over the short term the stock has risen 8.6% over the past week and 24.6% over the past month, while year to date it is down 17.6% and up 77.9% over the past year. These shifts can influence how the market prices risk and growth potential. These price moves sit against a backdrop of ongoing interest in database...

CAVA Group (CAVA) reported Q1 2026 results with Q4 2025 revenue at US$275 million and basic EPS of US$0.04, while trailing 12 month revenue stood at about US$1.18 billion with basic EPS of US$0.55 and a net income of US$63.7 million. Over the past year, revenue on a trailing 12 month basis moved from US$963.7 million with basic EPS of US$1.14 to US$1.18 billion with basic EPS of US$0.55. This gives investors a clearer view of how top line expansion has been paired with more modest per share...

Oshkosh (NYSE:OSK) unit McNeilus has introduced an AI-enabled contamination detection system for refuse and recycling vehicles. The system is designed to identify non compliant materials in recycling streams directly at the truck level. For Oshkosh, which builds specialty vehicles and equipment, this kind of product sits at the intersection of waste management operations and on board technology. Recycling operators face ongoing pressure to reduce contamination in collection streams, and...

Earlier in May 2026, AllianceBernstein Holding, Brookfield Asset Management and Carlyle launched ABC [ONE], a turnkey private-markets solution designed to give Defined Contribution retirement plans a single, professionally managed source of diversified private real assets and private equity exposure. The collaboration is material because it embeds private markets directly into Qualified Default Investment Alternatives, with allocations that automatically adjust as participants move through...

Butterfly Network (NYSE:BFLY) has appointed Caroll H. Neubauer to its Board of Directors. Neubauer brings decades of leadership experience in healthcare, including senior roles at B. Braun and industry groups such as AdvaMed. This board change shifts focus toward governance and execution after recent attention on valuation and share price moves. Butterfly Network, trading at $4.39, has had a mixed share price record recently, with the stock up 12% over the past week but down 20% over the...

Revolution Medicines reported groundbreaking overall survival results from its pivotal Phase 3 RASolute 302 trial of daraxonrasib in metastatic pancreatic cancer. The company entered a major clinical collaboration with Summit Therapeutics to study RAS(ON) inhibitor combinations across RAS mutant cancers. Revolution Medicines also announced plans to acquire EQRx, Inc., aiming to significantly increase its capital resources. These updates come as Revolution Medicines, ticker NasdaqGS:RVMD,...

Investors may be wondering if Worthington Enterprises at around US$54.66 is offering good value right now, or if the easy gains are already behind it. The stock is flat over the last 7 days, roughly flat over the last month with a 0.3% decline, up 5.2% year to date and still down 5.7% over the last year. The 3-year and 5-year returns of 61.9% and 49.8% show how different holding periods can feel very different. Recent coverage has focused on Worthington Enterprises as a diversified...

FLEX LNG (FLNG) is in focus after releasing first quarter 2026 results, affirming a cash dividend of $0.75 per share and raising its full year revenue guidance, giving investors fresh information on earnings, income and outlook. See our latest analysis for FLEX LNG. At a share price of $32.73, FLEX LNG has seen firm momentum build, with a 90 day share price return of 20.95% and a 1 year total shareholder return of 64.08%, pointing to growing investor interest around the latest earnings,...

ZIM Integrated Shipping Services (NYSE:ZIM) Q1 2026 earnings snapshot ZIM Integrated Shipping Services (NYSE:ZIM) has followed up its recent Q1 2026 report with a mixed set of trailing numbers, with the last four quarters showing total revenue of US$6.9b and basic EPS of US$3.98 on net income of US$479.2m, while the latest trailing net profit margin stands at 6.9% compared with 25.5% a year earlier. Over the past six reported quarters, revenue has moved from US$2.77b in Q3 2024 to US$1.48b in...

Before deciding whether Northern Trust stock looks attractive or expensive, it helps to be clear on what you are really paying for, and how that stacks up against what the business may be worth. Over the recent period, the stock has traded at US$165.96, with returns of 1.8% over 7 days, 4.4% over 30 days, 19.2% year to date, 61.5% over 1 year, 155.9% over 3 years and 59.6% over 5 years, which raises fair questions about how much of the story is already in the price. Alongside these moves,...

With Moody's stock at US$444.27, you might be wondering whether the current price still reflects a fair deal or if expectations have already been priced in. Recent returns have been mixed, with the stock up 1.4% over the last week, down 3.4% over the past month, down 11.0% year to date, and down 5.2% over the last year, while still showing a 47.3% gain over three years and 39.9% over five years. Recent news coverage has focused on Moody's role in credit ratings, analytics, and broader...

V2X (NYSE:VVX) has refreshed its board following its annual meeting, driven by its director age policy. Long-serving director Steven L. Waechter retired from the board under this policy. Committee roles were reassigned as part of the transition, aligning with the company’s stated governance framework. V2X, a government services and solutions company, operates in areas such as mission support, training, and technology-enabled services. Board composition is a key part of how a company sets...

If you are wondering whether Primoris Services at around US$106.69 is still offering value after a strong run, this article walks through what the current price might be implying. The stock has had a mixed run lately, with the share price down about 5.5% over the past week and roughly 35.2% over the past month, while still showing a 43.6% gain over the past year and a very large 304.8% return over three years, alongside a 259.1% return over five years. Recent coverage has focused on Primoris...

Executive change puts operational focus at center stage InnovAge Holding (INNV) shares moved after the company named Jennifer Browne as President and Chief Operating Officer, placing an experienced value-based care operator in charge of market operations and core support functions. See our latest analysis for InnovAge Holding. The appointment of Browne appears to come as investors reassess the story around InnovAge, with the stock showing a 1-year total shareholder return of 83.17% while...

Toll Brothers (TOL) opened its Q2 2026 earnings season with Q1 fiscal 2026 revenue of US$2.1 billion and basic EPS of US$2.20, setting a clear benchmark for how the rest of the year might shape up. Over recent quarters, the company has seen revenue move from US$3.3 billion in Q4 2024 to US$3.4 billion in Q4 2025 and EPS shift from US$4.67 to US$4.62 across those same periods. Trailing twelve month EPS stood at US$14.12 on revenue of US$11.3 billion in Q1 2026, giving investors a fuller read...

Red Cat Holdings (NasdaqCM:RCAT) has completed its acquisition of Quaze Technologies. The deal adds autonomous, platform agnostic wireless charging to Red Cat’s drone and robotics offerings. Quaze’s technology is intended to support air, land, and maritime unmanned systems across Red Cat’s portfolio and partner network. For you as an investor following unmanned systems, this move expands NasdaqCM:RCAT beyond drones into broader robotics infrastructure. Wireless power is emerging as a key...

8x8 (EGHT) has opened FY 2026 with steady top line and choppy bottom line results. Q3 revenue was US$185.1 million and basic EPS was US$0.04, compared with Q2 revenue of US$184.1 million and basic EPS of roughly US$0.01. The company’s revenue moved from US$180.0 million in FY 2025 Q2 to US$177.0 million in Q4 and then to US$185.1 million in FY 2026 Q3. Over the same periods, basic EPS ranged from a loss of about US$0.11 per share to a profit of around US$0.04 per share. Overall, the latest...

Earlier this month, Taylor Morrison Home reported first-quarter results that surpassed analyst expectations on revenue, earnings per share, and adjusted operating income, even as sales declined compared with a year earlier. The company’s ability to beat profit and operating forecasts while facing softer top-line trends highlights how its operating model and cost controls may be cushioning it against a cooling housing market. Now we’ll examine how this earnings beat, achieved despite...

Golar LNG (NasdaqGS:GLNG) has opened Q1 2026 earnings season with a backdrop of trailing 12 month revenue of US$393.5 million and basic EPS of US$0.64, alongside year over year earnings growth of 29.2% and a reported net margin of 16.7% versus 19.5% a year earlier. Over recent quarters, the company has seen quarterly revenue move from US$65.9 million in Q4 2024 to US$132.8 million in Q4 2025, with basic EPS shifting from US$0.04 to US$0.10 over the same period. This sets up a results picture...

Ghana’s mining regulator has directed AngloGold Ashanti (NYSE:AU) to transition certain mining operations to local contractors by December 2026. The mandate applies to AngloGold Ashanti and other operators in the country, setting a defined timeline for greater use of Ghanaian contractors. The change introduces a new regulatory requirement that could influence how AngloGold Ashanti structures its operations and engages with local suppliers. For investors watching NYSE:AU, this policy move...

Infinity Natural Resources (NYSE:INR) nearly doubled production following the integration of a major $1.2b asset acquisition from Antero. The integration marks a step change in the company’s operational scale within the natural gas segment. This development goes beyond routine quarterly updates, reshaping Infinity Natural Resources' production profile and operating footprint. Infinity Natural Resources now appears meaningfully different in size and scope than it did before the Antero deal,...